Cargando…
Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis
BACKGROUND: The coronavirus disease 2019 infection has significantly impacted the world and placed a heavy strain on the medical system and the public, especially those with cardiovascular diseases. Hoverer, the differences in door-to-balloon time and outcomes in ST-segment elevation myocardial infa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578758/ https://www.ncbi.nlm.nih.gov/pubmed/37832042 http://dx.doi.org/10.1097/MD.0000000000035612 |
_version_ | 1785121578549248000 |
---|---|
author | Bao, Qinxue Li, Rui Wang, Chengfeng Wang, Shan Cheng, Minli Pu, Chunhua Zou, Lei Liu, Chao Zhang, Qine Wang, Qun |
author_facet | Bao, Qinxue Li, Rui Wang, Chengfeng Wang, Shan Cheng, Minli Pu, Chunhua Zou, Lei Liu, Chao Zhang, Qine Wang, Qun |
author_sort | Bao, Qinxue |
collection | PubMed |
description | BACKGROUND: The coronavirus disease 2019 infection has significantly impacted the world and placed a heavy strain on the medical system and the public, especially those with cardiovascular diseases. Hoverer, the differences in door-to-balloon time and outcomes in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not known too much. METHODS: Web of Science, EMBASE, PubMed, Cochrane Library, Wanfang, VIP, and China’s National Knowledge Infrastructure were utilized to perform a systematic literature search until April 30, 2023. We computed the odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) to determine the correlation. A random-effects model was used for the meta-analysis if the study had significant heterogeneity. Meanwhile, sensitivity analysis and Trial sequential analysis were also accomplished using Rveman5.4 and trial sequential analysis 0.9.5.10 Beta software, respectively. RESULTS: A total of 5 eligible studies were explored in our meta-analysis, including 307 cases and 1804 controls. By meta-analysis, the pooled data showed that SARS-CoV-2-positive STEMI patients undergoing percutaneous coronary intervention had a longer door-to-balloon time (OR 6.31, 95% CI 0.99, 11.63, P = .02) than the negative subjects. The glycoprotein IIb/IIIa inhibitor use after SARS-CoV-2 infection (OR 2.71, 95% CI 1.53, 4.81, P = .0006) was relatively frequent compared with controls, and the postoperative Thrombolysis in Myocardial Infarction blood flow (OR 0.48, 95% CI 0.34, 0.67, P < .0001) was worse compared that. The in-hospital mortality (OR 5.16, 95% CI 3.53, 7.53, P < .00001) was higher than non-SARS-CoV-2 infection ones. In addition, we also discovered that age, gender (male), hypertension, diabetes mellitus, hyperlipidemia, smoking, previous myocardial infarction, total ischemia time, and thrombus aspiration use did not have a significant association with the development of STEMI patients with SARS-CoV-2. CONCLUSION: SARS-CoV-2 positivity is significantly associated with longer door-to-balloon time and higher in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention. |
format | Online Article Text |
id | pubmed-10578758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-105787582023-10-17 Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis Bao, Qinxue Li, Rui Wang, Chengfeng Wang, Shan Cheng, Minli Pu, Chunhua Zou, Lei Liu, Chao Zhang, Qine Wang, Qun Medicine (Baltimore) Systematic Review and Meta-Analysis BACKGROUND: The coronavirus disease 2019 infection has significantly impacted the world and placed a heavy strain on the medical system and the public, especially those with cardiovascular diseases. Hoverer, the differences in door-to-balloon time and outcomes in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are not known too much. METHODS: Web of Science, EMBASE, PubMed, Cochrane Library, Wanfang, VIP, and China’s National Knowledge Infrastructure were utilized to perform a systematic literature search until April 30, 2023. We computed the odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) to determine the correlation. A random-effects model was used for the meta-analysis if the study had significant heterogeneity. Meanwhile, sensitivity analysis and Trial sequential analysis were also accomplished using Rveman5.4 and trial sequential analysis 0.9.5.10 Beta software, respectively. RESULTS: A total of 5 eligible studies were explored in our meta-analysis, including 307 cases and 1804 controls. By meta-analysis, the pooled data showed that SARS-CoV-2-positive STEMI patients undergoing percutaneous coronary intervention had a longer door-to-balloon time (OR 6.31, 95% CI 0.99, 11.63, P = .02) than the negative subjects. The glycoprotein IIb/IIIa inhibitor use after SARS-CoV-2 infection (OR 2.71, 95% CI 1.53, 4.81, P = .0006) was relatively frequent compared with controls, and the postoperative Thrombolysis in Myocardial Infarction blood flow (OR 0.48, 95% CI 0.34, 0.67, P < .0001) was worse compared that. The in-hospital mortality (OR 5.16, 95% CI 3.53, 7.53, P < .00001) was higher than non-SARS-CoV-2 infection ones. In addition, we also discovered that age, gender (male), hypertension, diabetes mellitus, hyperlipidemia, smoking, previous myocardial infarction, total ischemia time, and thrombus aspiration use did not have a significant association with the development of STEMI patients with SARS-CoV-2. CONCLUSION: SARS-CoV-2 positivity is significantly associated with longer door-to-balloon time and higher in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention. Lippincott Williams & Wilkins 2023-10-13 /pmc/articles/PMC10578758/ /pubmed/37832042 http://dx.doi.org/10.1097/MD.0000000000035612 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | Systematic Review and Meta-Analysis Bao, Qinxue Li, Rui Wang, Chengfeng Wang, Shan Cheng, Minli Pu, Chunhua Zou, Lei Liu, Chao Zhang, Qine Wang, Qun Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis |
title | Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis |
title_full | Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis |
title_fullStr | Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis |
title_full_unstemmed | Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis |
title_short | Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis |
title_sort | differences in door-to-balloon time and outcomes in sars-cov-2-positive st-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis |
topic | Systematic Review and Meta-Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578758/ https://www.ncbi.nlm.nih.gov/pubmed/37832042 http://dx.doi.org/10.1097/MD.0000000000035612 |
work_keys_str_mv | AT baoqinxue differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT lirui differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT wangchengfeng differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT wangshan differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT chengminli differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT puchunhua differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT zoulei differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT liuchao differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT zhangqine differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis AT wangqun differencesindoortoballoontimeandoutcomesinsarscov2positivestsegmentelevationmyocardialinfarctionpatientsundergoingprimarypercutaneouscoronaryinterventionasystematicreviewandmetaanalysis |